PPM1D and ovarian serous adenocarcinoma: Therefore, Wip1 overexpression may be a potential therapeutic choice to block the metastasis and recurrence of serous ovarian cancer, however, further study is needed to better understand the function of Wip1 in tumor microenvironment.